Related Experiment Video
Updated: Oct 9, 2025

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022
Free Radicals and Neonatal Brain Injury: From Underlying Pathophysiology to Antioxidant Treatment Perspectives
Silvia Martini1,2, Laura Castellini3, Roberta Parladori4
1Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
Insights
Free radicals contribute to neonatal brain injury. Antioxidant therapies like hypothermia and magnesium sulfate are standard care, with ongoing research for better neuroprotection.
Area of Science:
- Neonatal neurology
- Oxidative stress research
- Neuroprotection strategies
Background:
- Free radicals are critical in neonatal brain injury development.
- Neonatal brain injury profiles vary based on free radical overproduction and patient-specific factors like gestational age (GA)-dependent antioxidant defenses and cerebrovascular autoregulation.
- Growing evidence highlights free radical damage to brain tissue.
Purpose of the Study:
- To review the role of free radicals in neonatal brain injury.
- To identify potential biomarkers for oxidative damage.
- To explore neuroprotective therapeutic approaches targeting oxidative stress in neonates.
Main Methods:
- Literature review of studies on free radicals, oxidative stress, and neonatal brain injury.
- Analysis of current evidence on biomarkers and therapeutic interventions.
- Evaluation of established and experimental neuroprotective treatments.
Main Results:
- Free radical overproduction is linked to distinct neonatal brain injury patterns.
- Potential biomarkers for oxidative damage have been identified, requiring further validation for clinical use.
- Therapeutic hypothermia and magnesium sulfate are established antioxidant treatments for reducing neonatal brain injury risk.
Conclusions:
- Optimizing neonatal neuroprotection requires implementing current evidence on oxidative brain injury.
- Individualized diagnostic and therapeutic strategies are needed.
- Further research and clinical trials are essential to improve neurological outcomes in neonates affected by oxidative brain injury.
Abstract:
Free radicals play a role of paramount importance in the development of neonatal brain injury. Depending on the pathophysiological mechanisms underlying free radical overproduction and upon specific neonatal characteristics, such as the GA-dependent maturation of antioxidant defenses and of cerebrovascular autoregulation, different profiles of injury have been identified. The growing evidence on the detrimental effects of free radicals on the brain tissue has led to discover not only potential biomarkers for oxidative damage, but also possible neuroprotective therapeutic approaches targeting oxidative stress. While a more extensive validation of free radical biomarkers is required before considering their use in routine neonatal practice, two important treatments endowed with antioxidant properties, such as therapeutic hypothermia and magnesium sulfate, have become part of the standard of care to reduce the risk of neonatal brain injury, and other promising therapeutic strategies are being tested in clinical trials. The implementation of currently available evidence is crucial to optimize neonatal neuroprotection and to develop individualized diagnostic and therapeutic approaches addressing oxidative brain injury, with the final aim of improving the neurological outcome of this population.

